Literature DB >> 6089859

Establishment of T and B cell lines from patients with mycosis fungoides.

K Kaltoft, K Thestrup-Pedersen, J R Jensen, S Bisballe, H Zachariae.   

Abstract

Eighteen patients with mycosis fungoides were studied in order to establish cell lines that might be associated with the human T cell leukaemia-lymphoma virus (HTLV). Three T cell lines were established, two from affected skin and one from a lymph node showing dermatopathic lymphadenopathy. The T cells expressed OKT3 and OKT4 antigens. They temporarily expressed an HTLV p19-like antigen in up to 5% of the cells during culture. None of our patients had lymphocytosis or abnormal lymphocytes, except one patient with Sézary's syndrome. We could not establish T cell lines from peripheral blood, but five B lymphoblastoid cell lines were obtained, all positive for the Epstein-Barr virus nuclear antigen. Our finding that T cell lines can be established from skin biopsies and lymph nodes of patients with mycosis fungoides, but not from the blood, supports the concept of a malignant T lymphocyte primarily localized in the skin. The temporary expression of HTLV p19 antigen may indicate the presence of retrovirus, but further studies are needed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089859     DOI: 10.1111/j.1365-2133.1984.tb04727.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.

Authors:  Anders Woetmann; Paola Lovato; Karsten W Eriksen; Thorbjørn Krejsgaard; Tord Labuda; Qian Zhang; Anne-Merethe Mathiesen; Carsten Geisler; Arne Svejgaard; Mariusz A Wasik; Niels Ødum
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

2.  Antibodies against retroviral core proteins in relation to disease outcome in patients with mycosis fungoides.

Authors:  A Ranki; K M Niemi; P Nieminen; K Krohn
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Natural and concanavalin A-induced cytotoxic activity towards continuously growing B lymphocytes derived from patients with cutaneous T-cell lymphoma.

Authors:  J R Jensen; K Kaltoft; S Bisballe; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 4.  Genotraumatic T cells and cutaneous T-cell lymphoma. A causal relationship?

Authors:  K Thestrup-Pedersen; K Kaltoft
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  A continuous T-cell line from a patient with Sézary syndrome.

Authors:  K Kaltoft; S Bisballe; H F Rasmussen; K Thestrup-Pedersen; K Thomsen; W Sterry
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

6.  AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair.

Authors:  Lilach Moyal; Neta Goldfeiz; Batia Gorovitz; Ada Rephaeli; Efrat Tal; Nataly Tarasenko; Abraham Nudelman; Yael Ziv; Emmilia Hodak
Journal:  Invest New Drugs       Date:  2017-09-08       Impact factor: 3.850

7.  The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.

Authors:  Lilach Moyal; Nataly Feldbaum; Neta Goldfeiz; Ada Rephaeli; Abraham Nudelman; Michal Weitman; Nataly Tarasenko; Batia Gorovitz; Leah Maron; Shiran Yehezkel; Iris Amitay-Laish; Ido Lubin; Emmilia Hodak
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.